Bioventus
Bioventus, established in 2012 and headquartered in Durham, North Carolina, is a global leader in developing and commercializing clinically differentiated, cost-efficient, and minimally invasive treatments that enhance the body's natural healing processes. The company operates across various segments, including pain treatments, restorative therapies, and surgical solutions. Bioventus's products are designed to support bone healing, manage chronic pain, and improve overall patient outcomes. The company's innovative offerings include the EXOGEN ultrasound bone healing system, DUROLANE hyaluronic acid joint therapy, and the StimRouter neuromodulation system for chronic pain management. Bioventus is committed to research and development, maintaining a robust pipeline of products aimed at addressing unmet medical needs in orthopedics and related fields. With a presence in over 50 countries and a team of more than 1,200 employees worldwide, Bioventus continues to expand its impact on global healthcare.
Bioventus Introduction
Established in 2012, Bioventus is a global leader of innovations for active healing. Through a combination of internal product development, product/business acquisition, and distribution agreements, the company brings to market products which address a growing need for clinically effective, cost efficient, minimally invasive medical treatments, that engage and enhance the body’s natural healing processes.
Bioventus Inc. (Nasdaq: BVS) is headquartered in Durham, NC. The company has more than 1,200 employees worldwide through its offices in USA, The Netherlands and manufacturing location in Hod Hasharon, Israel.